From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 1m 10s
Bio-Rad Shares Drop 5.2% in Sector Selloff
Bio-Rad Laboratories falls 5.2% as medical device stocks tumble in sector-wide selling.
In brief
Bio-Rad Laboratories falls 5.2% as medical device stocks tumble in sector-wide selling. Bio-Rad Laboratories shares dropped 5.2% on Thursday amid sector-wide selling pressure in medical devices and life sciences stocks. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Bio-Rad Shares Drop
Bio-Rad Laboratories tumbled 5.2% on Thursday as a sector-wide selloff dragged down medical device and life sciences stocks across the board.
Shares Closed at $357.93
Shares closed at $357.93, with the California-based company caught in a broader downdraft that sent several sector peers sharply lower on October 1, 2026.
Sector Peers Fell Too
Repligen Corporation (RGEN) fell 6.4%, Bruker Corporation (BRKR) down 3.3%, and Adaptive Biotechnologies (ADPT) off 3.7%.
Selloff Not Company-Specific
The decline wasn’t company-specific. Bio-Rad’s drop came alongside a wave of selling pressure that hit sector peers hard.
Market Capitalization at $9.6bn
Volume reached 118,017 shares as the stock shed value throughout the session, bringing Bio-Rad’s market capitalization to $9.6 billion.
What to Watch Next
Investors should monitor whether this sector weakness extends into Friday’s session or proves to be isolated repositioning.
The big picture
Bio-Rad Laboratories shares dropped 5.2% on Thursday amid sector-wide selling pressure in medical devices and life sciences stocks.
